Bespalov; Anton

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bespalov; Anton.The latest application filed is for "novel compositions, combinations, and methods thereof".

Company Profile

2.9.18

Bespalov; Anton - Heidelberg DE
Bespalov; Anton - WIESBADEN DE
Bespalov; Anton - Ludwigshafen N/A DE
Bespalov; Anton - Schifferstadt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Compositions, Combinations, And Methods Thereof App 20220296586 - Vepachedu; Sreenivasarao ; et al.	2022-09-22
Compositions and methods thereof Grant 11,103,499 - Vepachedu , et al. August 31, 2	2021-08-31
Compositions And Methods Thereof App 20210228508 - Vepachedu; Sreenivasarao ; et al.	2021-07-29
Compositions And Methods For Treatment Of Pain App 20210155597 - Gomtsian; Artour ; et al.	2021-05-27
Targeted Drug Rescue With Novel Compositions, Combinations, And Methods Thereof App 20200069674 - VEPACHEDU; SREENIVASARAO ; et al.	2020-03-05
Compositions And Methods Thereof App 20190183885 - Vepachedu; Sreenivasarao ; et al.	2019-06-20
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20150175570 - Turner; Sean Colm ; et al.	2015-06-25
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20140200224 - Turner; Sean Colm ; et al.	2014-07-17
1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor Grant 8,492,540 - Braje , et al. July 23, 2	2013-07-23
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor Grant 8,362,010 - Haupt , et al. January 29, 2	2013-01-29
N-phenyl-(piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenyl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20130018047 - Haupt; Andreas ; et al.	2013-01-17
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Grant 8,343,959 - Haupt , et al. January 1, 2	2013-01-01
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor Grant 8,183,237 - Haupt , et al. May 22, 2	2012-05-22
N-phenyl-(piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenyl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20120040969 - Haupt; Andreas ; et al.	2012-02-16
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20110319421 - Turner; Sean Colm ; et al.	2011-12-29
N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor Grant 8,076,326 - Haupt , et al. December 13, 2	2011-12-13
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20110086863 - Braje; Wilfried Martin ; et al.	2011-04-14
Use Of Substituted Oxindole Derivatives For The Treatment And Prophylaxis Of Pain App 20110059983 - Braje; Wilfried ; et al.	2011-03-10
1,2,4,-triazin-3,5-dione Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor App 20100311755 - Braje; Wilfried ; et al.	2010-12-09
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20100292220 - Haupt; Andreas ; et al.	2010-11-18
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20100292221 - Haupt; Andreas ; et al.	2010-11-18
N-phenyl- (piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20100280014 - Haupt; Andreas ; et al.	2010-11-04
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Grant 7,790,727 - Braje , et al. September 7, 2	2010-09-07
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor App 20090131452 - Braje; Wilfried Martin ; et al.	2009-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.